P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development

T. Velletri, N. Xie, Y. Wang, Y. Huang, Q. Yang, X. Chen, Q. Chen, P. Shou, Y. Gan, G. Cao, G. Melino, Y. Shi

Research output: Contribution to journalArticlepeer-review


It has been shown that p53 has a critical role in the differentiation and functionality of various multipotent progenitor cells. P53 mutations can lead to genome instability and subsequent functional alterations and aberrant transformation of mesenchymal stem cells (MSCs). The significance of p53 in safeguarding our body from developing osteosarcoma (OS) is well recognized. During bone remodeling, p53 has a key role in negatively regulating key factors orchestrating the early stages of osteogenic differentiation of MSCs. Interestingly, changes in the p53 status can compromise bone homeostasis and affect the tumor microenvironment. This review aims to provide a unique opportunity to study the p53 function in MSCs and OS. In the context of loss of function of p53, we provide a model for two sources of OS: MSCs as progenitor cells of osteoblasts and bone tumor microenvironment components. Standing at the bone remodeling point of view, in this review we will first explain the determinant function of p53 in OS development. We will then summarize the role of p53 in monitoring MSC fidelity and in regulating MSC differentiation programs during osteogenesis. Finally, we will discuss the importance of loss of p53 function in tissue microenvironment. We expect that the information provided herein could lead to better understanding and treatment of OS.

Original languageEnglish
Pages (from-to)e2015
JournalCell Death and Disease
Publication statusPublished - Jan 21 2016

ASJC Scopus subject areas

  • Cell Biology
  • Immunology
  • Cancer Research
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development'. Together they form a unique fingerprint.

Cite this